121 related articles for article (PubMed ID: 11019945)
1. Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
Azurdia RM; Dean MP; Rhodes LE
Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):186-8. PubMed ID: 11019945
[TBL] [Abstract][Full Text] [Related]
2. Can the immersion time of PUVA bath therapy be shortened?
Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
Acta Derm Venereol; 2002; 82(1):18-20. PubMed ID: 12013191
[TBL] [Abstract][Full Text] [Related]
3. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
4. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA.
Dolezal E; Seeber A; Hönigsmann H; Tanew A
Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):183-5. PubMed ID: 11019944
[TBL] [Abstract][Full Text] [Related]
5. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
6. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
Al-Ismail D; Edwards C; Anstey AV
Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
[TBL] [Abstract][Full Text] [Related]
7. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
[TBL] [Abstract][Full Text] [Related]
8. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
10. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
12. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
Sakuntabhai A; Farr PM; Diffey BL
Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
[TBL] [Abstract][Full Text] [Related]
13. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
14. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
[TBL] [Abstract][Full Text] [Related]
15. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
Ibbotson SH; Dawe RS; Farr PM
J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
[TBL] [Abstract][Full Text] [Related]
16. Assessment of minimal phototoxic dose following 8-methoxypsoralen bath: maximal reaction on average after 5 days.
Behrens-Williams S; Gruss C; Grundmann-Kollmann M; Peter RU; Kerscher M
Br J Dermatol; 2000 Jan; 142(1):112-5. PubMed ID: 10651704
[TBL] [Abstract][Full Text] [Related]
17. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
18. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
19. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
[TBL] [Abstract][Full Text] [Related]
20. An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Photochem Photobiol; 2003 Jul; 78(1):55-60. PubMed ID: 12929749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
